ENALARE THERAPEUTICS INC.

Profile

Company Names

ENALARE THERAPEUTICS INC.

Addresses

161 HODGE ROAD, PRINCETON, NJ 08540

Phone Numbers

609-325-7701

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$13,525,875.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2022-08-08 
$12,500,000.00 
$55,000,000.00 
$42,500,000.00 
Equity 
1
2022-02-07 
$1,025,875.00 
$10,000,000.00 
$8,974,125.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARK 
 
COLEMAN 
DIRECTOR
TANBIC LA CHOLLA, LP   |  NATIONAL SPINE + PAIN CENTERS HOLDINGS, LLC   |  TILT HOLDINGS INC.   |  ENALARE THERAPEUTICS INC.
HERMAN 
 
CUKIER 
EXECUTIVE OFFICER, DIRECTOR
ENALARE THERAPEUTICS INC.
DANIEL 
 
MOTTO 
EXECUTIVE OFFICER
ENALARE THERAPEUTICS INC.
JOSEPH 
 
PERGOLIZZI 
EXECUTIVE OFFICER, DIRECTOR
NEUMENTUM, INC.   |  ENALARE THERAPEUTICS INC.
JOSEPH 
 
PETKO 
DIRECTOR
ENALARE THERAPEUTICS INC.
GINO 
 
SANTINI 
DIRECTOR
HORIZON PHARMA, INC.   |  COLLEGIUM PHARMACEUTICAL INC   |  INTARCIA THERAPEUTICS, INC   |  ARTAX BIOPHARMA, INC.   |  ALLENA PHARMACEUTICALS, INC.   |  COLLEGIUM PHARMACEUTICAL, INC   |  ENALARE THERAPEUTICS INC.   |  ALZHEON, INC.
ROBERT 
 
YEDID 
DIRECTOR
ENALARE THERAPEUTICS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-08-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-08 
2022-02-07
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2022-02-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#